Target intelligence / Profile preview

High mobility group box 3 pseudogene 16 (HMGB3P16)

Target: HMGB3P16
Molecular classification: Other (Pseudogene)

Overview

High mobility group box 3 pseudogene 16 (HMGB3P16) is classified as a pseudogene, which means it is a genomic DNA sequence similar to a functional gene but typically nonfunctional due to mutations or lack of regulatory elements. There is no evidence that HMGB3P16 encodes a functional protein or serves as a therapeutic target. Pseudogenes like HMGB3P16 are generally considered biologically inactive and are not associated with drug targeting, disease mechanisms, or biomarker applications.

Other names: High mobility group box 3 pseudogene 16HMGB3P16

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 16 (HMGB3P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 16 (HMGB3P16).

Explore the full profile